Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Dupixent (dupilumab) for the Treatment of Atopic Dermatitis

Drug (Brand / Generic)

Dupixent (dupilumab)

Product Description

Human monoclonal antibody

Current Indication

Moderate-to-severe Atopic Dermatitis and asthma


Sanofi and Regeneron

Development Status

Approved in the US, the EU, Canada and Japan

Go Top